Table 1.
Baseline cardiovascular measurements
| Early Phase |
Late Phase |
|||||
|---|---|---|---|---|---|---|
| Sham (n = 10) | RDNX (n = 10) | Renal-CAP (n = 10) | Sham (n = 8) | RDNX (n = 9) | Renal-CAP (n = 9) | |
| MAP, mmHg | 139 ± 3 | 140 ± 3 | 138 ± 2 | 166 ± 4 | 169 ± 6 | 169 ± 5 |
| HR, bpm | 396 ± 3 | 401 ± 4 | 396 ± 4 | 386 ± 3 | 392 ± 5 | 396 ± 6 |
Mean arterial pressure (MAP) and heart rate (HR) on the day before treatment surgery in Sham, renal denervation (RDNX), and renal-CAP (selective ablation of afferent renal nerves) rats in both the early-phase and late-phase protocols. There were no statistical differences in MAP or HR between groups in either protocol.